OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Prevalence and Outcomes of COVID-19 among Hematology/Oncology Patients and Providers of a Community-Facing Health System during the B1.1.529 (“Omicron”) SARS-CoV-2 Variant Wave
Samuel A. Kareff, Aliya Khan, Priscila Barreto‐Coelho, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4629-4629
Open Access | Times Cited: 6
Samuel A. Kareff, Aliya Khan, Priscila Barreto‐Coelho, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4629-4629
Open Access | Times Cited: 6
Showing 6 citing articles:
Sequential or Combination Treatments as Rescue Therapies in Immunocompromised Patients with Persistent SARS-CoV-2 Infection in the Omicron Era: A Case Series
Bianca Maria Longo, Francesco Venuti, Alberto Gaviraghi, et al.
Antibiotics (2023) Vol. 12, Iss. 9, pp. 1460-1460
Open Access | Times Cited: 9
Bianca Maria Longo, Francesco Venuti, Alberto Gaviraghi, et al.
Antibiotics (2023) Vol. 12, Iss. 9, pp. 1460-1460
Open Access | Times Cited: 9
Charting a path forward: Promising outcomes of convalescent plasma therapy in the care of severely B‐cell depleted patients with persistent COVID ‐19
Tsofia Inbar, Eldad J. Dann, Omer Kerner, et al.
Transfusion (2024) Vol. 64, Iss. 3, pp. 443-448
Closed Access | Times Cited: 2
Tsofia Inbar, Eldad J. Dann, Omer Kerner, et al.
Transfusion (2024) Vol. 64, Iss. 3, pp. 443-448
Closed Access | Times Cited: 2
Clinical Outcomes in Patients With COVID-19 and Hematologic Disease
O. A. Aleshina, Kristina Zakurdaeva, Anastasia Vasileva, et al.
Clinical Lymphoma Myeloma & Leukemia (2023) Vol. 23, Iss. 8, pp. 589-598
Open Access | Times Cited: 6
O. A. Aleshina, Kristina Zakurdaeva, Anastasia Vasileva, et al.
Clinical Lymphoma Myeloma & Leukemia (2023) Vol. 23, Iss. 8, pp. 589-598
Open Access | Times Cited: 6
Timing of BNT162b2 vaccine prior to COVID ‐19 infection, influence disease severity in patients with hematologic malignancies: Results from a cohort study
Odit Gutwein, Katrin Herzog Tzarfati, Arie Apel, et al.
Cancer Medicine (2023) Vol. 12, Iss. 21, pp. 20503-20510
Open Access | Times Cited: 3
Odit Gutwein, Katrin Herzog Tzarfati, Arie Apel, et al.
Cancer Medicine (2023) Vol. 12, Iss. 21, pp. 20503-20510
Open Access | Times Cited: 3
Prevalence and Clinical Outcome of Omicron Breakthrough Infection in Patients With Hematologic Disease: A Prospective Observational Cohort Study
Kentaro Narita, Daisuke Ikeda, Mizuki Seki, et al.
HemaSphere (2023) Vol. 7, Iss. 6, pp. e905-e905
Open Access
Kentaro Narita, Daisuke Ikeda, Mizuki Seki, et al.
HemaSphere (2023) Vol. 7, Iss. 6, pp. e905-e905
Open Access
Prevalence and clinical outcome of Omicron breakthrough infection in patients with hematologic disease: a prospective observational cohort study
Kentaro Narita, Daisuke Ikeda, Mizuki Seki, et al.
Research Square (Research Square) (2022)
Open Access
Kentaro Narita, Daisuke Ikeda, Mizuki Seki, et al.
Research Square (Research Square) (2022)
Open Access
